Clinical Trial Update: Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting [Phase 4]

View source ↗

Summary

This Phase 4 open-label study evaluated the long-term safety and tolerability of pimecrolimus cream 1% in pediatric patients with atopic dermatitis in a routine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Elidel (pimecrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED